康弘药业 · CHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD
Ownership & governance
Executives 5Directors 10Avg age 56Avg tenure 10.3y
ZK
Zun Hong Ke
Chairman
Age 72Since 2013-06-20
+14
Executives5
JZ
Jian Jun Zhong
Director of Finance/CFO
Age 59—
XK
Xiao Ke
President
Age 43Since 2019-12-26
JY
Jin Qun Yin
Corporate Officer/Principal
Age 54Since 2013-06-20
JZ
Jian Rong Zhong
Corporate Officer/Principal
Age 69Since 2011-12-31
GL
Gao Lei Liu
Investor Relations Contact
——
Board of directors10
ZK
Zun Hong Ke
Chairman
Age 72Since 2013-06-20
XK
Xiao Ke
Director/Board Member
Age 43Since 2011-12-31
JZ
Jian Rong Zhong
Director/Board Member
Age 69Since 2011-12-31
WG
Wen Xian Gong
Chairman
Age 79Since 2011-12-31
YY
Yin Ying Yang
Director/Board Member
Age 40Since 2016-09-18
LW
Lin Wang
Director/Board Member
Age 58Since 2011-12-31
JY
Jin Qun Yin
Director/Board Member
Age 54Since 2019-12-26
DZ
De Min Zhou
Director/Board Member
Age 60Since 2023-08-02
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Da Cheng Fund Management Co., Ltd. | 4.58 % | 31,641,160 |
| Orient Securities Asset Management Co. Ltd. | 1.284 % | 8,871,928 |
| China Southern Asset Management Co., Ltd. | 0.833 % | 5,755,267 |
| Yinhua Fund Management Co., Ltd. | 0.6615 % | 4,570,118 |
| ICBC UBS Asset Management Co. Ltd. | 0.6068 % | 4,192,360 |
Catalog · 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus none
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.